3. There is evidence that the company’s philanthropic activities (excluding drug donation programmes) are aligned with and support implementation of national health system development plans and stated health priorities in the Index countries.
3. There is evidence that the company’s philanthropic activities (excluding drug donation programmes) are aligned with and support implementation of national health system development plans and stated health priorities in the Index countries.